黑料网

ISSN: 2475-3173

Cervical Cancer: 黑料网
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Asfold Parfenov

Russia
Publications

Immune-Mediated Colitis with Concurrent Clostridium Difficile Infection

Immune checkpoint inhibitors (ICIs) are widely used for patients with primary lung cancer in the recent years and have better overall survival versus previously used chemotherapy [1]. Some adverse events of immunotherapy, such as diarrhea and colitis, can lead to treatment discontinuation due to the risk of fatal outcome. We present the case of pem... Read More»

Saria Dbar, Sariya Alekperzade, Elena Sabelnikova, Olga Akhmadullina, Svetlana Bykova, Filonenko Darya and Asfold Parfenov

: Cervical Cancer 2022, 7:134

10.4172/2475-3173.1000134

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics
International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top